文献速递乳腺US

超声造影定量参数评估局部晚期乳腺癌新辅助化疗反应

Contrast enhanced ultrasound quantitative parameters for assessing neoadjuvant chemotherapy response in patients with locally advanced breast cancer.
PubMed 文献 · Br J Radiol · 2021-04-16

研究纳入30例局部晚期乳腺癌患者,在新辅助化疗前及每周期后3周行超声造影定量分析,发现反应良好者峰值增强下降、达峰时间和平均通过时间延长。第三周期后达峰时间的诊断准确率为87.2%,提示超声造影可早期预测化疗反应。

要点

  • 超声造影定量参数峰值增强、达峰时间和平均通过时间可用于评估新辅助化疗反应。
  • 反应良好者化疗后峰值增强下降,达峰时间和平均通过时间延长。
  • 第三周期后达峰时间的诊断准确率较高,有助于早期调整化疗方案。

关键影像表现/征象

  • 反应良好者随新辅助化疗周期增加,峰值增强均值下降,达峰时间和平均通过时间均值延长。
  • 每周期化疗后与基线相比,反应良好者与反应不良者之间峰值增强、达峰时间和平均通过时间的百分比变化有统计学显著差异(p<0.05)。

诊断标准与关键数值

  • 第三周期后达峰时间的诊断准确率为87.2%(p=0.03)。
  • 第二周期后平均通过时间的诊断准确率为76.7%(p=0.004),第三周期后为86.7%(p=0.006)。

临床应用与阅片要点

  • 可在新辅助化疗期间利用超声造影定量参数早期识别反应良好者,辅助临床调整化疗方案。
  • 关注峰值增强下降及达峰时间、平均通过时间延长等变化趋势。

局限性

  • 样本量较小(30例),可能影响结果的普遍性。
  • 单中心研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the role of contrast-enhanced ultrasound (CEUS) quantitative parameters in predicting neoadjuvant chemotherapy (NACT) response in patients with locally advanced breast cancer (LABC).

METHODS: 30 patients with histologically proven LABC scheduled for NACT were recruited. CEUS was performed using a contrast bolus of 4.8 ml and time intensity curves (TICs) were obtained by contrast dynamics software. CEUS quantitative parameters assessed were peak enhancement (PE), time-to-peak (TTP), area under the curve (AUC) and mean transit time (MTT). The parameters were documented on four consecutive instances: before NACT and 3 weeks after each of the three cycles. The gold-standard was pathological response using Miller Payne Score obtained pre NACT and post-surgery.

RESULTS: A decrease in mean values of PE and an increase in mean values of TTP and MTT was observed with each cycle of NACT among responders. Post each cycle of NACT (compared with baseline pre-NACT), there was a statistically significant difference in % change of mean values of PE, TTP and MTT between good responders and poor responders (p-value < 0.05). The diagnostic accuracy of TTP post-third cycle was 87.2% (p = 0.03), and MTT post--second and third cycle was 76.7% (p = 0.004) and 86.7% (p = 0.006) respectively.

CONCLUSION: In responders, a decrease in the tumor vascularity was reflected in the CEUS quantitative parameters as a reduction in PE, and a prolongation in TTP, MTT.

ADVANCES IN KNOWLEDGE: Prediction of NACT response by CEUS has the potential to serve as a diagnostic modality for modification of chemotherapy regimens during ongoing NACT among patients with LABC, thus affecting patient prognosis.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Sharma A, Grover SB, Mani C, et al. Contrast enhanced ultrasound quantitative parameters for assessing neoadjuvant chemotherapy response in patients with locally advanced breast cancer. Br J Radiol. 2021. PMID: 33860674. doi:10.1259/bjr.20201160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。